NEW YORK, Feb. 06, 2017 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired shares of Stemline Therapeutics,
Inc. (“Stemline”) (NASDAQ:STML) between January 20,
2017 and February 1, 2017. You are hereby notified that Levi & Korsinsky has commenced the class action
Braswell v. Stemline Therapeutics, et al. (Case No. 1:17-cv-00853) in the USDC for the Southern District of New York.
Click here to view the complaint. To get more information go to:
http://www.zlk.com/pslra/stemline-therapeutics
or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no
cost or obligation to you.
The complaint alleges that during the class period the Company made materially false and/or misleading
statements and/or failed to disclose that: (i) a patient had died in the BPDCN Trial from capilliary leak syndrome immediately
prior to the Company’s stock offering despite consistently stating that capillary leak syndrome was a potential side-effect of
SL-401; and (ii) SL-401’s safety profile did not remain predictable and manageable over increasing treatment duration, drug
exposure, and patient experience as represented by the Defendants.
Take Action: if you suffered a loss in Stemline Therapeutics you have until April 4, 2017 to request that the Court appoint you as lead plaintiff.
Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The
firm’s attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered
hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar
outcomes.
CONTACT: Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com
